Endonovo Therapeutics Inc (ENDV): They have been uncharacteristically quie...

Reply Private New

Replies (1) Next 10 Prev Next

Send PM Follow Ignore

Re: BlackDoggie post# 8221

Wednesday, 04/26/2017 6:51:05 PM

Wednesday, April 26, 2017 6:51:05 PM

They have been uncharacteristically quiet aside from the March PR. I think they are preparing for a strong campaign after the results are released. They have gotten a private strategic investor involved to get this uplisted, that means pps will need to rise dramatically first. I would expect a lot of marketing and expose the next few months, again beginning with results. There were several articles out earlier this month.

https://www.insiderfinancial.com/endonovo-therapeutics-inc-otcmktsendv-should-run-further-near-term/120717/

https://streetregister.com/2017/04/06/endonovo-therapeutics-inc-otcmktsendv-shares-could-continue-to-rise-after-these-recent-developments/

http://oracledispatch.com/2017/04/04/endonovo-therapeutics-inc-otcmktsendv-shares-break-recent-range/

http://www.rfdtv.com/story/35044520/biotechs-that-are-heating-up

Keep Last Read

Replies (1) Next 10 Prev Next

Form 15-12G - Securities registration termination [Section 12(g)] • Edgar (US Regulatory) • 02/02/2024 10:23:02 PM
Form 8-K - Current report • Edgar (US Regulatory) • 01/03/2024 10:30:14 PM
Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend] • Edgar (US Regulatory) • 12/29/2023 08:20:36 PM
Form 8-K - Current report • Edgar (US Regulatory) • 12/04/2023 02:08:41 PM
Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 11/15/2023 05:21:48 PM
Form 8-K - Current report • Edgar (US Regulatory) • 10/12/2023 10:03:32 AM
Form 1-A/A - Offering Statement [Regulation A]: [Amend] • Edgar (US Regulatory) • 08/25/2023 11:04:33 AM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/21/2023 09:16:04 PM

InvestorsHub NewsWire

Only $200 per official company press release!